Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2022 Aug 4;165(5):e225–e236. doi: 10.1016/j.jtcvs.2022.07.016

Table 1:

Inflammatory protein expression in ischemic myocardium of EV-treated swine.

Protein Median (IQR) P Value

Pro-Inflammatory
NFκB 0.80 (0.70–0.84) 0.002
P-NFκB 0.75 (0.72–0.79) 0.029
Pro-IL1β 0.83 (0.67–0.86) 0.020
CD11c 0.49 (0.42–0.57) 0.001
HLA-DRA 0.78 (0.71–1.03) 0.66
IL-6 0.79 (0.61–0.94) 0.28
TNF-α 0.85 (0.79–0.95) 0.35
TLR4 1.17 (0.86–1.26) 0.49
TLR2 0.87 (0.67–0.89) 0.18
iNOS 1.02 (0.97–1.13) 0.57
CD40 0.79 (0.69–1.0) 0.18
Anti-Inflammatory
IL-10 1.20 (1.18–1.46) 0.020
CD163 1.59 (1.19–1.83) 0.043
Arginase 1.10 (0.64–1.32) 0.85
NFκβ Regulators
IKB-α 0.95 (0.86–1.00) 0.41
p-IKB-α 0.92 (0.81–1.02) 0.85

Statistics presented as median fold change (interquartile range) in extracellular vesicle (EV) treated swine (n=8) compared to average control (n=6). P values calculated using Wilcoxon rank-sum test.